Login

Anton Pillay, CEO of Coronation Fund Managers, discusses the company's adjustment to payment processes in a "#PayIn30" initiative. 00:10:00

Share On Facebook Share On Twitter

Anton Pillay, CEO of Coronation Fund Managers,

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Kingfisher Metals: Advancing High-Grade Exploration in British Columbia
00:10:00
CapMan's Emphasis on Dividends: Insights from CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.
00:10:00
UOB's Quality Growth Strategy: Antony Creighton and Dharmo Soejanto Discuss Key Drivers for Sustainable Returns | Dharmo Soejanto - Antony Creighton
00:10:00
invest in missiondriven founders who embrace big big ideas big impact big risk|Hunter Walk,Partner,Homebrew
00:10:00
Paul Canvert: Driving Recruitment & Retention in Transport | Paul Sarant - CEO, MD & Executive Director of K&S Corporation Limited
00:10:00
Student Loan Planning for Medical Graduates | Tristan Crook, CERTIFIED FINANCIAL PLANNER of 308 Financial
00:10:00
Bob Sulentic, CBRE Group CEO, and Lars Norell, Altus Power co-founder and co-CEO, discuss the decision to go public on "Squawk on the Street."
00:00:00
Medivir presentation - Jens Lindberg, CEO, Medivir
00:10:00
Oregon needs a leader who will challenge conventional thinking, innovate, and make state government accountable to the taxpayer|Allen Alley,CEO,pixelworks inc
00:00:00
Sumera I. Ilyas, M.B.B.S. Transplant Hepatologist, Mayo Clinic / Ask Mayo Clinic: Cirrhosis
00:10:00
Vista Gold's Fred Earnest Updates Post-Earnings & Gold Market Insights | FREDERICK H. EARNEST - President and Chief Executive Officer of Vista Gold Corp.
00:10:00
Interview with the Managing Director of ARSP Mr. Miguel | Miguel KATEMB KASHAL, MANAGING DIRECTOR, ARSP

© 2026 Nehu